Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Hellström
Jeanette Hellström, Goteborg SE
| Patent application number | Description | Published |
|---|---|---|
| 20090259208 | HYDROENTANGLED NONWOVEN FABRIC, METHOD OF MAKING IT AND ABSORBENT ARTICLE CONTAINING THE FABRIC - A nonwoven fabric comprising at least 50% by weight microfibers having a fineness of 1.0 dtex or less and a length of at least 30 mm and having been combined by hydroentangling. The fabric is apertured by said hydroentangling, and has been carded before hydroentangling. The fabric may be used as a topsheet material on an absorbent article. | 10-15-2009 |
| 20100249741 | NON-WOVEN MATERIAL FOR USE AS A BODY FACING SHEET IN AN ABSORBENT ARTICLE - A nonwoven material including at least two layers integrated into each other, for use as a body facing sheet in an absorbent article. The first layer includes spunlaid filaments and the second layer includes staple fibres. The staple fibres have a thickness ≦1.5 dtex, and the filaments have a thickness ≧2.5 dtex. Further, an absorbent article, such as a sanitary napkin, panty liner, incontinence protector or diaper can include the nonwoven material as a body facing sheet. | 09-30-2010 |
Karin Hellström, Trosa SE
| Patent application number | Description | Published |
|---|---|---|
| 20100004319 | Composition and Method for the Prevention, Treatment and/or Alleviation of an Inflammatory Disease - A method for enhancing the clinical responsiveness to an anti-inflammatory therapy in a patient afflicted with an inflammatory condition, comprising administering an oligonucleotide having the sequence 5′-Xm-CG-Yn-3′ in an effective amount to said patient, and wherein X is A, T, C or G; Y is A, T, C or G; m=1-40; n=1-40 and wherein at least one CG dinucleotide is unmethylated. The invention also encompasses the use of such an oligonucleotide for the manufacture of a medicament for enhancing steroid efficacy in the treatment of a patient afflicted with an inflammatory condition. | 01-07-2010 |
Mats Hellström, Uppsala SE
| Patent application number | Description | Published |
|---|---|---|
| 20090209473 | Componds and methods for pormoting angiogenesis - Angiogenesis may be initiated or increased through the use of gamma-secretase inhibitors. The gamma-secretase inhibitor can be a dipeptide class, sulfonamide class, transition state mimic class, benzodiazepine class, or benzocaprolactam class gamma secretase inhibitor. Methods for initiating and increasing angiogenesis are used for disease prevention and treatment as well as for generating research models. | 08-20-2009 |
| 20100119526 | DLL4 Signaling Inhibitors and Uses Thereof - DLL4-binding antibodies, specifically antibodies preventing Notch signaling and internalization of DLL4, can: more efficiently than inhibitors only preventing DLL4-mediated Notch-signaling disrupt angiogenesis and pathological processes including tumor growth. | 05-13-2010 |